Published in Biotechniques on June 01, 2005
Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41
Quantitative matrix-assisted laser desorption/ionization mass spectrometry. Brief Funct Genomic Proteomic (2008) 1.09
Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology (2005) 3.83
Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A (2008) 3.41
FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho. J Cell Physiol (2008) 3.10
The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem (2004) 2.46
GOAT links dietary lipids with the endocrine control of energy balance. Nat Med (2009) 2.42
Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res (2005) 1.81
Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. Science (2003) 1.77
New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. J Neurosci (2007) 1.62
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochim Biophys Acta (2004) 1.43
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther (2002) 1.43
A simplified procedure for the reduction and alkylation of cysteine residues in proteins prior to proteolytic digestion and mass spectral analysis. Anal Biochem (2004) 1.38
Strategic use of immunoprecipitation and LC/MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal Chem (2007) 1.36
Characteristic physical properties and structural fragments of marketed oral drugs. J Med Chem (2004) 1.36
Estimating the statistical significance of peptide identifications from shotgun proteomics experiments. J Proteome Res (2007) 1.30
The effects of vertical sleeve gastrectomy in rodents are ghrelin independent. Gastroenterology (2012) 1.28
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.22
Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase. Biochem Biophys Res Commun (2002) 1.14
The impact of blood contamination on the proteome of cerebrospinal fluid. Proteomics (2005) 1.12
Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism. J Neurosci (2009) 1.07
Fast top-down intact protein characterization with capillary zone electrophoresis-electrospray ionization tandem mass spectrometry. Anal Chem (2013) 1.06
Proteomics: from hypothesis to quantitative assay on a single platform. Guidelines for developing MRM assays using ion trap mass spectrometers. Brief Funct Genomic Proteomic (2008) 1.04
The role of mass spectrometry in biomarker discovery and measurement. Curr Drug Metab (2006) 1.03
Capillary zone electrophoresis-electrospray ionization-tandem mass spectrometry for top-down characterization of the Mycobacterium marinum secretome. Anal Chem (2014) 1.01
Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor. J Cell Biochem (2007) 0.99
Alloxan is an inhibitor of O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem Biophys Res Commun (2006) 0.94
Label-free LC-MS method for the identification of biomarkers. Methods Mol Biol (2008) 0.93
Quantitative analysis of amyloid-beta peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry. Brief Funct Genomic Proteomic (2007) 0.92
Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling. Biochemistry (2009) 0.92
A proteomic analysis of adult rat bone reveals the presence of cartilage/chondrocyte markers. J Cell Biochem (2007) 0.92
Recombinant human thrombomodulin inhibits arterial neointimal hyperplasia after balloon injury. J Vasc Surg (2004) 0.88
Geometric accuracy of three-dimensional molecular overlays. J Chem Inf Model (2006) 0.86
Chemical fragments as foundations for understanding target space and activity prediction. J Med Chem (2008) 0.85
Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem Pharmacol (2003) 0.85
An immuno-chemo-proteomics method for drug target deconvolution. J Proteome Res (2008) 0.84
Quantitative Proteomics via High Resolution MS Quantification: Capabilities and Limitations. Int J Proteomics (2013) 0.83
A quantitative tool to distinguish isobaric leucine and isoleucine residues for mass spectrometry-based de novo monoclonal antibody sequencing. J Am Soc Mass Spectrom (2014) 0.82
Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma. Anal Biochem (2013) 0.82
Application of proteomics for discovery of protein biomarkers. Brief Funct Genomic Proteomic (2003) 0.81
Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity. J Proteome Res (2007) 0.80
Determination of cathepsin S abundance and activity in human plasma and implications for clinical investigation. Anal Biochem (2012) 0.80
Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration. J Mol Neurosci (2010) 0.79
Quantification of heart fatty acid binding protein as a biomarker for drug-induced cardiac and musculoskeletal necroses. Proteomics Clin Appl (2007) 0.79
Epitope mapping of antibodies by mass spectroscopy: a case study. Methods Mol Biol (2013) 0.79
From ghrelin to ghrelin's O-acyl transferase. Methods Enzymol (2012) 0.78
Small-molecule affinity chromatography coupled mass spectrometry for drug target deconvolution. Expert Opin Drug Discov (2009) 0.78
Capture of drug targets from live cells using a multipurpose immuno-chemo-proteomics tool. J Proteome Res (2009) 0.77
Structure-guided expansion of kinase fragment libraries driven by support vector machine models. Biochim Biophys Acta (2009) 0.77
The diabetogenic antibiotic streptozotocin modifies the tryptic digest pattern for peptides of the enzyme O-GlcNAc-selective N-acetyl-beta-d-glucosaminidase that contain amino acid residues essential for enzymatic activity. Biochem Pharmacol (2006) 0.77
Proteomics of cerebrospinal fluid: methods for sample processing. Methods Mol Biol (2008) 0.77
Glucose stimulates the tyrosine phosphorylation of Crk-associated substrate in pancreatic beta-cells. J Biol Chem (2003) 0.76
Identifying pharmacodynamic protein markers of centrally active drugs in humans: a pilot study in a novel clinical model. J Proteome Res (2007) 0.75
Circulating Markers Reflect Both Anti- and Pro-Atherogenic Drug Effects in ApoE-Deficient Mice. Biomark Insights (2008) 0.75
Evaluating the performances of quantitative structure-retention relationship models with different sets of molecular descriptors and databases for high-performance liquid chromatography predictions. J Chromatogr A (2009) 0.75
Quantitative biological mass spectrometry. Editorial. Brief Funct Genomic Proteomic (2008) 0.75
Proteomics technologies for identification and validation of protein targets. Methods Biochem Anal (2005) 0.75